These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 38782223)

  • 1. Dual-strain dynamics of COVID-19 variants in India: Modeling, analysis, and implications for pandemic control.
    Singh Negi S; Sharma N; Mehmet Baskonus H
    Gene; 2024 Oct; 926():148586. PubMed ID: 38782223
    [TBL] [Abstract][Full Text] [Related]  

  • 2. COVID-19 pandemic dynamics in India, the SARS-CoV-2 Delta variant, and implications for vaccination.
    Yang W; Shaman J
    medRxiv; 2021 Nov; ():. PubMed ID: 34845460
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analysis of the impact of COVID-19 variants and vaccination on the time-varying reproduction number: statistical methods.
    Jang G; Kim J; Lee Y; Son C; Ko KT; Lee H
    Front Public Health; 2024; 12():1353441. PubMed ID: 39022412
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mutations make pandemics worse or better: modeling SARS-CoV-2 variants and imperfect vaccination.
    Bugalia S; Tripathi JP; Wang H
    J Math Biol; 2024 Mar; 88(4):45. PubMed ID: 38507066
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Unraveling the dynamics of the Omicron and Delta variants of the 2019 coronavirus in the presence of vaccination, mask usage, and antiviral treatment.
    Ngonghala CN; Taboe HB; Safdar S; Gumel AB
    Appl Math Model; 2023 Feb; 114():447-465. PubMed ID: 36281307
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Modeling the Transmission of the SARS-CoV-2 Delta Variant in a Partially Vaccinated Population.
    Avila-Ponce de León U; Avila-Vales E; Huang K
    Viruses; 2022 Jan; 14(1):. PubMed ID: 35062363
    [TBL] [Abstract][Full Text] [Related]  

  • 7. COVID-19 pandemic dynamics in India, the SARS-CoV-2 Delta variant and implications for vaccination.
    Yang W; Shaman J
    J R Soc Interface; 2022 Jun; 19(191):20210900. PubMed ID: 35670221
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Optimal control strategies on COVID-19 infection to bolster the efficacy of vaccination in India.
    Rajput A; Sajid M; Tanvi ; Shekhar C; Aggarwal R
    Sci Rep; 2021 Oct; 11(1):20124. PubMed ID: 34635703
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mathematical modeling of mutated COVID-19 transmission with quarantine, isolation and vaccination.
    Wang F; Cao L; Song X
    Math Biosci Eng; 2022 Jun; 19(8):8035-8056. PubMed ID: 35801456
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relevance of immune response and vaccination strategies of SARS-CoV-2 in the phase of viral red queen dynamics.
    Jacob JJ; John Fletcher G; Monisha Priya T; Veeraraghavan B; Mutreja A
    Indian J Med Microbiol; 2021; 39(4):417-422. PubMed ID: 34454775
    [TBL] [Abstract][Full Text] [Related]  

  • 11. COVID-19 vaccines: Keeping pace with SARS-CoV-2 variants.
    Cevik M; Grubaugh ND; Iwasaki A; Openshaw P
    Cell; 2021 Sep; 184(20):5077-5081. PubMed ID: 34534444
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A mathematical model of COVID-19 with multiple variants of the virus under optimal control in Ghana.
    Kim YR; Min Y; Okogun-Odompley JN
    PLoS One; 2024; 19(7):e0303791. PubMed ID: 38954691
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical severity of, and effectiveness of mRNA vaccines against, covid-19 from omicron, delta, and alpha SARS-CoV-2 variants in the United States: prospective observational study.
    Lauring AS; Tenforde MW; Chappell JD; Gaglani M; Ginde AA; McNeal T; Ghamande S; Douin DJ; Talbot HK; Casey JD; Mohr NM; Zepeski A; Shapiro NI; Gibbs KW; Files DC; Hager DN; Shehu A; Prekker ME; Erickson HL; Exline MC; Gong MN; Mohamed A; Johnson NJ; Srinivasan V; Steingrub JS; Peltan ID; Brown SM; Martin ET; Monto AS; Khan A; Hough CL; Busse LW; Ten Lohuis CC; Duggal A; Wilson JG; Gordon AJ; Qadir N; Chang SY; Mallow C; Rivas C; Babcock HM; Kwon JH; Halasa N; Grijalva CG; Rice TW; Stubblefield WB; Baughman A; Womack KN; Rhoads JP; Lindsell CJ; Hart KW; Zhu Y; Adams K; Schrag SJ; Olson SM; Kobayashi M; Verani JR; Patel MM; Self WH;
    BMJ; 2022 Mar; 376():e069761. PubMed ID: 35264324
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modeling the Impact of Vaccination on COVID-19 and Its Delta and Omicron Variants.
    Wang J; Chan YC; Niu R; Wong EWM; van Wyk MA
    Viruses; 2022 Jul; 14(7):. PubMed ID: 35891462
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The potential health and economic value of SARS-CoV-2 vaccination alongside physical distancing in the UK: a transmission model-based future scenario analysis and economic evaluation.
    Sandmann FG; Davies NG; Vassall A; Edmunds WJ; Jit M;
    Lancet Infect Dis; 2021 Jul; 21(7):962-974. PubMed ID: 33743846
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Protection against symptomatic infection with delta (B.1.617.2) and omicron (B.1.1.529) BA.1 and BA.2 SARS-CoV-2 variants after previous infection and vaccination in adolescents in England, August, 2021-March, 2022: a national, observational, test-negative, case-control study.
    Powell AA; Kirsebom F; Stowe J; Ramsay ME; Lopez-Bernal J; Andrews N; Ladhani SN
    Lancet Infect Dis; 2023 Apr; 23(4):435-444. PubMed ID: 36436536
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immune Evasive Effects of SARS-CoV-2 Variants to COVID-19 Emergency Used Vaccines.
    Zhang Y; Banga Ndzouboukou JL; Gan M; Lin X; Fan X
    Front Immunol; 2021; 12():771242. PubMed ID: 34880867
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modeling the dynamics of COVID-19 in the presence of Delta and Omicron variants with vaccination and non-pharmaceutical interventions.
    Saha S; Saha AK
    Heliyon; 2023 Jul; 9(7):e17900. PubMed ID: 37539217
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Critical assessment of the impact of vaccine-type and immunity on the burden of COVID-19.
    Taboe HB; Asare-Baah M; Iboi EA; Ngonghala CN
    Math Biosci; 2023 Jun; 360():108981. PubMed ID: 36803672
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vaccine effectiveness against SARS-CoV-2 infection or COVID-19 hospitalization with the Alpha, Delta, or Omicron SARS-CoV-2 variant: A nationwide Danish cohort study.
    Gram MA; Emborg HD; Schelde AB; Friis NU; Nielsen KF; Moustsen-Helms IR; Legarth R; Lam JUH; Chaine M; Malik AZ; Rasmussen M; Fonager J; Sieber RN; Stegger M; Ethelberg S; Valentiner-Branth P; Hansen CH
    PLoS Med; 2022 Sep; 19(9):e1003992. PubMed ID: 36048766
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.